Kadmon Holdings Llc (KDMN) Stock News
NASDAQ:KDMN - Nasdaq -
KDMN Latest News, Press Relases and Analysis
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
Pay Consultant Gets Prison for Insider Trades in $1.9 Billion Sanofi-Kadmon Deal
An executive pay consultant will spend a year and a day behind bars for insider trading in connection with Sanofi SA’s $1.9 billion acquisition of biotech firm Kadmon Holdings Inc.
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus J&J to Separate Its Consumer Health Business Into a New Publicly Traded...
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Kadmon Holdings, Inc. (KDMN) Reports Q3 Loss, Tops Revenue Estimates
Kadmon Holdings, Inc. (KDMN) delivered earnings and revenue surprises of 0.00% and 3393.11%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the United States - - Execution of strategic launch strategy underway; Third quarter REZUROCK net sales $12.2 million - - Sanofi acquisition of Kadmon expected to close 4Q 2021 - NEW YORK, NY / ACCESSWIRE / November 4, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today provided a business update and reported
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TGP, ESBK, KDMN, VNE; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / October 8, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Teekay LNG Partners L.P. (NYSE:TGP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Stonepeak for $17.00 in cash per common unit or common unit equivalent. If you are a Teekay LNG shareholder, click here to learn more
Kadmon Announces Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer's 36th Annual Meeting
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion protein, in patients with metastatic or locally advanced solid tumors, in addition to other IL-15 preclinical work, at the Society for Immunotherapy of Cancer's (SITC 2021) 36th Annual Meeting, taking place virtually November 10 - 14, 2021. Details of
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MDLA, MSON, KDMN, ECHO; Shareholders are Encouraged to Contact the Firm
NEW YORK, NY / ACCESSWIRE / September 24, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Medallia, Inc. (NYSE: MDLA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thoma Bravo for $34.00 per share in cash.If you are a Medallia shareholder, click here to learn more about your rights and options. Misonix,
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Kadmon Holdings, Inc. - KDMN
SHAREHOLDER ALERT: WeissLaw LLP Investigates Kadmon Holdings, Inc.
Mentions: SNY
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kadmon Holdings, Inc.
Mentions: SNY